tyvasohcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: *.pdf Sitemap: | ||
Meta Tags
| Title | TYVASO® (treprostinil) Inhalation Solution and TYVASO DPI® (treprostinil) Inhalation Powder | HCP |
| Description | TYVASO IS AN INHALED PROSTACYCLIN APPROVED FOR 2 Healthcare Professional website for TYVASO® and TYVASO DPI®, inhaled prostacyclin mimetics approved for the treatment of PAH and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.45.59 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tyvasohcp.com Valuation
|
US$4,172,789
Last updated: 2023-04-27 05:19:27
tyvasohcp.com has Semrush global rank of 2,536,506. tyvasohcp.com has an estimated worth of US$ 4,172,789, based on its estimated Ads revenue. tyvasohcp.com receives approximately 481,476 unique visitors each day. Its web server is located in United States, with IP address 45.60.45.59. According to SiteAdvisor, tyvasohcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,172,789 |
| Daily Ads Revenue | US$3,852 |
| Monthly Ads Revenue | US$115,555 |
| Yearly Ads Revenue | US$1,386,650 |
| Daily Unique Visitors | 32,099 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tyvasohcp.com. | A | 299 | IP: 45.60.45.59 |
| tyvasohcp.com. | A | 299 | IP: 45.60.106.59 |
| tyvasohcp.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| tyvasohcp.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| tyvasohcp.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| tyvasohcp.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| tyvasohcp.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| tyvasohcp.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| tyvasohcp.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| tyvasohcp.com. | TXT | 3600 | TXT Record: facebook-domain-verification=2et5ir60qn7ku7f0vnid9peukt9uiu |
| tyvasohcp.com. | TXT | 3600 | TXT Record: google-site-verification=2B6J6xbpTKybOgNyhvKVrdFz2tdhXhmsMB7m5w7-bCc |
| tyvasohcp.com. | TXT | 3600 | TXT Record: globalsign-domain-verification=54342A42223730487BB76A3574558C3C |
HtmlToTextCheckTime:2023-04-27 05:19:27
| TYVASO DPI IS NOW APPROVED Learn more Important Safety Information Prescribing Information TYVASO TYVASO DPI Instructions for Use TYVASO TYVASO DPI Patient Site FOR US HEALTHCARE PROFESSIONALS ONLY TYVASO and TYVASO DPI are prostacyclin mimetics. FOR US HEALTHCARE PROFESSIONALS ONLY SELECT INDICATION PH-ILD (WHO GROUP 3) PAH (WHO GROUP 1) SELECT INDICATION PH-ILD (WHO GROUP 3) PAH (WHO GROUP 1) TYVASO IS AN INHALED PROSTACYCLIN APPROVED FOR 2 INDICATIONS 1 PH-ILD (WHO Group 3) 1 Pulmonary hypertension associated with interstitial lung disease PAH (WHO Group 1) 1 Pulmonary arterial hypertension TYVASO DPI ® THE PROVEN EFFICACY OF TYVASO ® IN THE PALM OF YOUR HAND 1,2 TYVASO DPI Inhalation Powder is a simple-to-use, inhaled prostacyclin therapy that delivers the trusted safety and benefits of TYVASO. 1,2 Get the details about TYVASO DPI. LEARN MORE CLOSE DPI=dry powder inhaler. References: 1. TYVASO DPI [package insert]. Research Triangle Park, NC: United Therapeutics Corporation; 2022. |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.tyvasohcp.com/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: max-age=600 content-length: 304310 content-type: text/html expires: Wed, 20 Oct 2021 11:41:04 GMT last-modified: Tue, 25 May 2021 17:35:30 GMT accept-ranges: bytes etag: "4a4b6-5c32af3d46dc4" vary: Accept-Encoding server: Apache strict-transport-security: max-age=31536000;includeSubDomains; x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff date: Wed, 20 Oct 2021 11:31:04 GMT set-cookie: visid_incap_2519395=WQQT3d8hSGOBctlejPeiXvj9b2EAAAAAQUIPAAAAAAB1lHmM7YrFR3G642Mfjr1w; expires=Thu, 20 Oct 2022 09:32:18 GMT; HttpOnly; path=/; Domain=.tyvasohcp.com set-cookie: nlbi_2519395=cBLAKP+BdRhnisWZLyhTfAAAAACoBVF8vdJge9HmgyVbnMXx; path=/; Domain=.tyvasohcp.com set-cookie: incap_ses_7221_2519395=vql1XqDgcwbBpCsAjSU2ZPj9b2EAAAAAIbrAqB/9By2aaq2cP5UEtA==; path=/; Domain=.tyvasohcp.com x-cdn: Imperva x-iinfo: 13-39893142-39893143 NNNN CT(25 77 0) RT(1634729464592 0) q(0 0 1 0) r(2 2) U12 |
tyvasohcp.com Whois Information
Domain Name: TYVASOHCP.COM Registry Domain ID: 2588635155_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-06-22T17:00:51Z Creation Date: 2021-02-01T19:28:47Z Registry Expiry Date: 2024-02-01T19:28:47Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T00:26:56Z <<< |